Close

Moleculin Biotech (MBRX) Receives Positive FDA Guidance Regarding Annamycin IND Submission

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. ISRG
3. TSM
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. NVDA
10. SLB


Go back to Moleculin Biotech (MBRX) Receives Positive FDA Guidance Regarding Annamycin IND Submission
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 4.65 +0.13 (2.88%)
Previous Close $4.52    52 Week High $9.58 
Open $4.59    52 Week Low $2.34 
Day High $4.66    P/E N/A 
Day Low $4.40    EPS $-0.34 
Volume 10,562